Guardant Health Strikes Multi-Cancer Screening Partnership to Widen Distribution Reach

Deal signals a retail/access expansion play for Guardant's liquid biopsy franchise, but commercial ramp hinges on unresolved CMS reimbursement pathways and unconfirmed MCED regulatory status.

bt-corporate · 7/3/2026, 2:01:09 PM · Ask about this →